- Biopsy
- To confirm receptor status and provide tissue for further testing re clinical trial eligibility
- Consider radiotherapy to rib lesion for pain relief (best to do early rather than need to interrupt systemic treatment)
- Dr Marita Morgia’s team to arrange appointment
- Clinical trial
- JAVELIN PARP Medley trial (avelumab plus talazoparib)– Prof Richard Kefford at Macquarie University Hospital
- b. Other options include:
- Keytruda (pembrolizumab) – self-funded
- Another clinical trial
- ARCS- Multi tumour (anetumab ravtansine in mesothelin expressing advanced solid tumours) – Prof Richard Kefford at Macquarie University Hospital
- Xgeva (denosumab) to treat and protect bones (to be discussed)
3 Aug 18